Sarah James
Stock Analyst at Cantor Fitzgerald
(1.96)
# 3,114
Out of 5,113 analysts
300
Total ratings
34.67%
Success rate
-7.55%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $14.41 | +17.97% | 18 | Dec 3, 2025 | |
| CNC Centene | Maintains: Neutral | $38 → $41 | $39.02 | +5.07% | 16 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $77.72 | +22.23% | 16 | Oct 30, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $227 → $250 | $227.46 | +9.91% | 27 | Oct 29, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $196.33 | +24.79% | 23 | Oct 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $210 → $180 | $163.69 | +9.96% | 14 | Oct 24, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $15.70 | +129.30% | 13 | Oct 7, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | $4 | $2.35 | +70.21% | 8 | Oct 7, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $444 | $472.98 | -6.13% | 21 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $327.42 | +34.38% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $271.89 | +34.25% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $26.63 | +5.14% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $259.40 | +11.80% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $340.69 | +42.36% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $22.38 | +29.58% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $3.23 | +364.40% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $0.89 | +461.80% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.23 | +38.31% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $115.20 | +15.45% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $27.16 | +54.64% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $6.00 | -16.67% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $9.09 | -44.99% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $20.42 | +2.84% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $76.68 | -49.14% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $77.35 | +149.52% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.26 | - | 2 | Mar 1, 2017 |
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $14.41
Upside: +17.97%
Centene
Oct 30, 2025
Maintains: Neutral
Price Target: $38 → $41
Current: $39.02
Upside: +5.07%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $77.72
Upside: +22.23%
Universal Health Services
Oct 29, 2025
Maintains: Neutral
Price Target: $227 → $250
Current: $227.46
Upside: +9.91%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $196.33
Upside: +24.79%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $210 → $180
Current: $163.69
Upside: +9.96%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $15.70
Upside: +129.30%
Health Catalyst
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $2.35
Upside: +70.21%
HCA Healthcare
Oct 7, 2025
Reiterates: Overweight
Price Target: $444
Current: $472.98
Upside: -6.13%
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $327.42
Upside: +34.38%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $271.89
Upside: +34.25%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $26.63
Upside: +5.14%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $259.40
Upside: +11.80%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $340.69
Upside: +42.36%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $22.38
Upside: +29.58%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $3.23
Upside: +364.40%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $0.89
Upside: +461.80%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.23
Upside: +38.31%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $115.20
Upside: +15.45%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $27.16
Upside: +54.64%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $6.00
Upside: -16.67%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $9.09
Upside: -44.99%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $20.42
Upside: +2.84%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $76.68
Upside: -49.14%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $77.35
Upside: +149.52%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.26
Upside: -